IRIS
ZENTILIN, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.437
AS - Asia 2.121
NA - Nord America 1.248
SA - Sud America 190
AF - Africa 23
OC - Oceania 7
Totale 25.026
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.083
US - Stati Uniti d'America 1.164
SG - Singapore 860
CN - Cina 594
VN - Vietnam 371
FR - Francia 181
BR - Brasile 117
HK - Hong Kong 81
BD - Bangladesh 65
CA - Canada 40
DE - Germania 37
GB - Regno Unito 35
AR - Argentina 33
FI - Finlandia 30
IN - India 29
MX - Messico 28
JP - Giappone 26
IQ - Iraq 21
EC - Ecuador 14
NL - Olanda 14
IE - Irlanda 11
PH - Filippine 11
ID - Indonesia 10
VE - Venezuela 9
ES - Italia 8
TR - Turchia 8
JO - Giordania 6
CL - Cile 5
CO - Colombia 5
JM - Giamaica 5
LT - Lituania 5
RU - Federazione Russa 5
TH - Thailandia 5
AU - Australia 4
CH - Svizzera 4
OM - Oman 4
PE - Perù 4
SA - Arabia Saudita 4
TW - Taiwan 4
DZ - Algeria 3
NP - Nepal 3
PL - Polonia 3
PY - Paraguay 3
UA - Ucraina 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
FJ - Figi 2
GT - Guatemala 2
KR - Corea 2
MA - Marocco 2
NI - Nicaragua 2
PK - Pakistan 2
PT - Portogallo 2
SE - Svezia 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UG - Uganda 2
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MY - Malesia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
TG - Togo 1
Totale 25.026
Salva come PNG Salva come JPEG
Città #
Genova 12.851
Genoa 4.952
Rapallo 1.742
Vado Ligure 1.357
San Jose 383
Singapore 382
Lauterbourg 171
Ho Chi Minh City 133
Ashburn 102
Beijing 96
New York 85
Hong Kong 80
Hanoi 76
Council Bluffs 48
Orem 35
Santa Clara 35
Bordighera 34
Los Angeles 32
Frankfurt am Main 29
Helsinki 25
Tokyo 25
Mexico City 19
Da Nang 17
Milan 17
Buffalo 15
Tianjin 15
St Louis 13
Dallas 12
Haiphong 12
Montreal 12
Chicago 11
Atlanta 10
Boardman 10
Dublin 10
Poplar 10
Rome 10
Amsterdam 9
Chennai 9
City of London 8
Phoenix 8
São Paulo 8
Toronto 8
Guangzhou 7
Hải Dương 7
Amman 6
Memphis 6
Mumbai 6
Naples 6
Quito 6
Seattle 6
Baghdad 5
Brooklyn 5
Can Tho 5
Lappeenranta 5
London 5
San Francisco 5
Shanghai 5
Thái Bình 5
Bologna 4
Columbus 4
Curitiba 4
Kingston 4
Lima 4
Muscat 4
Padua 4
Piscataway 4
Rio de Janeiro 4
Salvador 4
Shenzhen 4
Vĩnh Long 4
Zurich 4
Basra 3
Biên Hòa 3
Boston 3
Cagliari 3
Cardiff 3
Charlotte 3
Des Moines 3
Dhaka 3
Greensboro 3
Guayaquil 3
Las Vegas 3
Manchester 3
North Olmsted 3
Paris 3
Philadelphia 3
Qingdao 3
Querétaro 3
Salt Lake City 3
Sydney 3
Tampa 3
Tashkent 3
Thái Nguyên 3
Warsaw 3
Abidjan 2
Ankara 2
Bandung 2
Bangkok 2
Billings 2
Borgosesia 2
Totale 23.139
Salva come PNG Salva come JPEG
Nome #
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 240
Proton pump inhibitors: use and misuse in the clinical setting 239
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 219
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers 218
Advancements in the use of manometry and impedance testing for esophageal functional disorders 206
Time pattern of gastric acidity in Barrett's esophagus 205
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 201
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 201
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 200
A safety review of proton pump inhibitors to treat acid-related digestive diseases 199
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 198
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 195
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 193
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 191
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 191
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 190
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 188
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 188
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. 184
The relevance of symptom association analysis in GORD patients undergoing anti-reflux surgery 183
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 183
Cell proliferation of squamous epithelium in gastro-oesophageal reflux disease: correlations with clinical, endoscopic and morphological data 183
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 182
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 180
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 175
Achalasia with Dense Eosinophilic Infiltrate Responding To Steroidal Treatment. 173
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 173
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 173
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 170
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 169
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 167
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 166
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 166
Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations 164
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 163
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 163
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 158
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 156
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 156
Endotherapy for and tailored approaches to treating GERD, and refractory GERD 156
Esophageal biopsies in the management of GERD: complementary tool for many but not for all. 156
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 155
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 155
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. 154
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 154
NERD: an umbrella term including heterogeneous subpopulations. 154
The appropriate use of proton-pump inhibitors 154
24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes. 153
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 152
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. 149
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole 149
Esophageal acid exposure still plays a major role in patients with NERD. 149
Epidemiology and natural history of gastroesophageal reflux disease 149
Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori 148
Helicobacter pylori and tolerance to H2-blockers. 148
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity 147
Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring. 145
Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease. 145
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. 143
Overweight is a risk factor for both erosive and non-erosive reflux disease. 142
Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? 141
MIB-1 Proliferation Index of squamous epithelium in gastroesophageal reflux disease. Correlations with clinical, Endoscopic and Morphological data. 141
[Esophageal pH monitoring: factors influencing the definition of normality]. 140
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study 139
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. 139
The role of Acid in functional dyspepsia. 138
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 138
The relevance of weakly acidic reflux in patients with Barrett's esophagus. 138
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. 137
Studies on factors predicting GORD response to proton-pump inhibitors: NERD subpopulations need to be analysed separately. 136
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 136
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 135
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 135
Relevance of measuring substances in bronchoalveolar lavage fluid for detecting aspiration-associated extraesophageal reflux disease 135
Basal cell hyperplasia and dilatation of intercellular spaces are the main histologic features associated to the endoscopic/impedance-pH diagnosis of GERD and its related mucosal integrity impairment 134
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 134
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation 134
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. 133
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. 133
Limitations of continuous 24-h intragastric pH monitoring in the diagnosis of duodenogastric reflux 133
Nonerosive reflux disease and functional heartburn are clearly separate entities. 133
Pathophysiological studies are mandatory to understand the benefit of proton pump inhibitors in patients with idiopathic pulmonary fibrosis 133
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. 132
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 130
Comment to "current applications of evolving methodologies in gastroesophageal reflux disease testing". 130
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 130
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 130
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 130
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 129
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 129
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. 129
Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage. 129
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. 128
Pathophysiological characteristics of long- and short-segment Barrett's oesophagus. 128
Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infection. 125
Non-erosive reflux disease is more complex than negative endoscopy only. 124
Functional testing: pharyngeal pH monitoring and high-resolution manometry. 124
Circadian gastric acidity and Helicobacter pylori infection in patients with chronic pancreatitis. 123
Intragastric acidity and serum gastrin after sufotidine. 123
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? 123
Totale 15.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.506
article - articoli 70.112
book - libri 506
conference - conferenze 989
curatela - curatele 0
other - altro 6.803
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.096
Totale 159.012
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 0 0 100
2021/20222.102 107 156 179 282 75 144 163 405 82 210 65 234
2022/20232.094 223 130 21 190 442 312 1 167 367 13 203 25
2023/20241.019 49 123 24 115 94 157 64 49 59 21 83 181
2024/20253.309 160 253 152 206 440 331 284 494 133 133 360 363
2025/20265.844 728 157 447 576 652 595 935 263 491 601 313 86
Totale 25.293